In this article, originally appearing on IFLR.com, MoFo attorneys Jake Robson, Gordon Milner and Nick Davis provide guidelines for FinTech companies or companies collaborating with FinTech businesses to manage rapidly evolving regulations in the ASEAN countries.
The Fourth District Court of Appeals in San Diego on November 1, 2018, issued AMN Healthcare Inc. v. Aya Healthcare Services Inc., in which it called into question the continuing viability in California of employee non-solicitation clauses found in many employment contracts and proprietary information, invention assignment, and confidentiality agreements.
In this article, which originally appeared on corporatesecretary.com, Morrison & Foerster corporate attorneys discuss (1) the implications to a company of failing to obtain and document board approval of certain actions, (2) the areas where board approval is most likely to be neglected, and (3) best practices for board resolutions and approvals.
In August, Massachusetts’ Governor signed into law the Massachusetts Noncompetition Agreement Act establishing strict new requirements for noncompetition agreements with employees entered on or after October 1, 2018. Read our client alert.
What steps should startups take before raising venture capital financing? Morrison & Foerster Emerging Companies + Venture Capital partner John Rafferty outlines the top six things founders should do before raising venture capital in his recent article for the Silicon Valley Business Journal. Read the full Silicon Valley Business Journal article.
Intellectual property issues can be critical at the time a startup is considering a sale. In this video, partner Tim Harris explains several reasons why an acquirer will scrutinize a startup’s intellectual property before moving forward with a purchase.
Careful IP planning is especially important in the life sciences, in which companies often rely on only a handful of patents to protect a high-market value product such as an FDA-approved drug. In this article, MoFo counsel Lisa Silverman details the importance of patent protection for life sciences companies, highlighting the long-term benefits of patent term extension and how to identify which assets to prioritize. Originally appearing in the Daily Journal, read the article here.